Review on therapeutic trials for coronavirus disease-19

Medical Journal of Babylon

article

Ayam M Salih¹  Khalida K Abbas Al-Kelaby²  Jawad R Al-Zaidi³ 

[1] Department of Microbiology, Hammurabi College of Medicine, University of Babylon;Department of Clinical and Laboratory Sciences, Faculty of Pharmacy, Kufa University;Department of Medical Lab Technology, Shatrah Technical College, Southern Technical University

关键词: Control;    coronavirus disease-19;    diagnosis;    prevention;    treatments;   

DOI  :  10.4103/MJBL.MJBL_103_20

学科分类：社会科学、人文和艺术（综合）

来源: Wolters Kluwer Medknow Publications

【 摘 要 】

Our world was gripped by the coronavirus disease-19 (COVID-19) pandemic during the first months of the year 2020. It has been characterized as a new coronavirus (i.e., severe acute respiratory syndrome-CoV-2, which is an acute severe respiratory syndrome coronavirus, and later, it has been referred to as the coronavirus disease-19 or COVID-19. Whereas this disease has been originated in Wuhan city in the Chinese province of Hubei, it was capable of rapidly spreading all over the world, which has resulted in a human disaster as well as massive economic damages. By the middle of June 2020, there were more than 8 million COVID-19 cases all over the world, with more than 436,000 death cases. The aim of this review study was to investigate the most effective therapeutic trials for COVID-19.

【 授权许可】

CC BY-NC-SA